Vimarsana
Biggest News Aggregation in the World

Page 3 - Expanded Special Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Special Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Special Project Today - Breaking & Trending Today

Accelerating efforts to combat Neglected Tropical Diseases in Liberia - Liberia - Vimarsana News

Accelerating efforts to combat Neglected Tropical Diseases in Liberia - Liberia

News and Press Release in English on Liberia about Health and Epidemic; published on 1 Dec 2022 by WHO

What Will It Take to Eliminate Neglected Tropical Diseases Once and for All? - Vimarsana News

What Will It Take to Eliminate Neglected Tropical Diseases Once and for All?

Neglected tropical diseases (NTDs) fuel a vicious cycle of poor health and poverty — but they can be eliminated. Here’s how.

WHO Unveils New Analytical Tools on the ESPEN Data Portal - Vimarsana News

WHO Unveils New Analytical Tools on the ESPEN Data Portal

Page Not Found | ZAWYA MENA Edition

Source: zawya.com
Toward the Elimination of Female Genital Schistosomiasis (FGS), By Alfred Kwesi Manyeh - Vimarsana News

Toward the Elimination of Female Genital Schistosomiasis (FGS), By Alfred Kwesi Manyeh

Toward the Elimination of Female Genital Schistosomiasis (FGS), By Alfred Kwesi Manyeh FGS is threatening the reproductive and sexual health of women and girls. As we celebrate the World Health Day with the focus on “Building a Fairer, and Healthier World”, there is the need for more concerted effort toward awareness creation, detection, treatment and prevention of FGS, together with other concomitant women’s health challenges or else FGS will remain a neglected gynaecological disease. Schistosomiasis is a water-borne parasitic disease caused by infection with Schistosoma blood flukes ...

Hope rising for Lassa fever vaccine - Vimarsana News

Hope rising for Lassa fever vaccine

Punch Newspapers Sections IT is heartening that efforts are ongoing to develop a vaccine for Lassa fever. An American biotechnology company, INOVIO, which is spearheading the research, noted that the first participant in Lassa vaccine trial had been dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever. The clinical trial in progress in Ghana is reportedly focusing on offering precisely-designed DNA medicines to treat and protect people from infectious diseases and cancer. Lassa fever, according to the United States Centres for Disease Control and Prevent...